Kinetic sells notes to pay for LifeCell:
This article was originally published in Clinica
Advanced woundcare company Kinetic Concepts said it plans to raise $600m through a sale of convertible senior notes to help fund its acquisition of biosurgery firm LifeCell. The two companies agreed to a $1.7bn all-cash deal earlier this month (see Clinica No 1301, p 2). San Antonio, Texas-based Kinetic also plans to use the proceeds from the note sale to pay off debt, for ongoing working capital and for other general corporate purposes of the combined company. The convertible notes are due to mature in 2015.
You may also be interested in...
Europe's largest online pharmacy is calling for online sales of OTC medicines to be allowed in its home market Switzerland, to increase the supply of crucial products to help people manage the symptoms of COVID-19, such as headaches, fever, diarrhoea, coughs, colds or nausea.
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Novartis's Jakavi joins the likes of Roche's Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients.